Kane Biotech Inc (KNE)

TSXV
0.09
+0.01(+0.00%)
  • Volume:
    30,000
  • Bid/Ask:
    0.08/0.09
  • Day's Range:
    0.08 - 0.09

KNE Overview

Prev. Close
0.08
Day's Range
0.08-0.09
Revenue
2.39M
Open
0.09
52 wk Range
0.08-0.17
EPS
-0.037
Volume
30,000
Market Cap
11.23M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
53,364
P/E Ratio
-2.05
Beta
0.229
1-Year Change
-52.94%
Shares Outstanding
124,830,202
Next Earnings Date
-
What is your sentiment on Kane Biotech?
or
Vote to see community's results!

Kane Biotech Inc News

Kane Biotech Inc Analysis

Kane Biotech Inc Company Profile

Kane Biotech Inc Company Profile

Employees
0
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA4838092084
  • CUSIP:483809208

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell